NCT00666653View on ClinicalTrials.gov

Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Parkinson's Disease

Interventions

DRUG

pramipexole

Trial Locations (1)

97239

Oregon Health & Science University, Portland

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT00666653 - Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease | Biotech Hunter | Biotech Hunter